Patent details
EP3083991 Title: BIOMARKERS FOR HBV TREATMENT RESPONSE
Basic Information
- Publication number:
- EP3083991
- PCT Application Number:
- EP2014077667
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP148208051
- PCT Publication Number:
- WO2015091306
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- BIOMARKERS FOR HBV TREATMENT RESPONSE
- French Title of Invention:
- BIOMARQUEURS POUR LA RÉPONSE AU TRAITEMENT DU VIRUS DE L'HÉPATITE B
- German Title of Invention:
- BIOMARKER FÜR DAS ANSPRECHEN AUF EINE HBV-BEHANDLUNG
- SPC Number:
Dates
- Filing date:
- 15/12/2014
- Grant date:
- 14/03/2018
- EP Publication Date:
- 26/10/2016
- PCT Publication Date:
- 25/06/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/03/2018
- EP B1 Publication Date:
- 14/03/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/12/2018
- Expiration date:
- 15/12/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/03/2018
- Name:
- F. Hoffmann-La Roche AG
- Address:
- Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)
Inventor
1
- Name:
- WAT, Cynthia
- Address:
- United Kingdom (GB)
2
- Name:
- HE, Hua
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 13197711
- Priority Date:
- 17/12/2013
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- C12Q 1/68;
Publication
European Patent Bulletin
- Issue number:
- 201811
- Publication date:
- 14/03/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/04/2019 | Outgoing Correspondence | 1 |